We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

The Challenges Of Valuing Litigation-Driven Equities

Law360 (August 30, 2018, 12:34 PM EDT) -- Many eyes are on the Delaware Court of Chancery to see whether it will compel Fresenius SE to close on a $4.5 billion acquisition of generic drugmaker Akorn Inc. Fresenius terminated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.